The EPS projection of Humana Inc. (NYSE:HUM) for quarter ended 2016-09-30 is $2.79. Last week, the projection for EPS was $2.79 against target of $2.79, a month earlier. While 2-months ago, this projection was $2.79 versus forecast of $2.79a quarter months earlier, posting a deviation of 0%.
Humana Inc. (NYSE:HUM) posted that 18 days earlier, the share price was revised 8 times on upside. In addition, negative revisions were 0.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 1 times. In last one-month and two month the positive revisions were 1 and 2. While in last 120 and 90 days, positive revisions were 5, and 5, correspondingly.
The per-share earnings downgrade for Humana Inc. (NYSE:HUM) in the preceding 30 and 120 were 0 and 4. While in 60 and 90 days were 0, and 4, in that order.
Humana Inc. (NYSE:HUM) EPS target was $2.79 for the quarter closed 1. It was based on 12 calls. As on 2016-05-04 the EPS was $1.86. The change was $0.05, posting a deviation of 2.76%. The price projections gave a standard deviation of 0.02.
Quarterly Sales Estimates
Humana Inc. (NYSE:HUM) sales prediction for the fiscal 2017 stands at $14231.702 and the median estimate is at $14053.22. Almost 5 analysts gave sales target.
Among this, the highest sales estimate is $14919 while the lowest target is $13544.6 showing standard deviation of 543.83%.
As many as 5 analysts have positive sales targets revision while 5 reduced sales estimates, posting a deviation of 0%.
Last month, 5 experts have positive sales number revision. Also, 5 research groups lowered the sales projections, posting a deviation of 0.067%.
A quarter ago, 5 hiked sales target and 5 reduced sales forecast, posting a deviation of -0.18%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...